There are many people in the world of business that choose to create a path of higher excellence and focus on climbing the ladder of success. But there are few business professionals who while climbing the ladder of success take a significant amount of their time to also give back to the world through significant philanthropic work, but Matthew Autterson is such a person.
With a career that spans over three and a half decades and a volunteering career of over two and a half decades, it is clear that Mr. Autterson has prioritized blending his professional time with a financial career and a philanthropic one.
He graduated from Michigan State University with a B.A. in Finance in 1980 and furthered his education by attending the University of Denver Graduate Tax Program. This education became the foothold of a long and prosperous career for Matthew.
Just two years after he graduated from college in 1982, Matt helped incorporate a new Colorado state-chartered trust company. This trust company known as Resources Trust Company in part by his leadership became a multibillion dollar company. This company became known as SunAmerica with assets totaling over $21 billion dollars.
His Philanthropic Imprint
While building Resources Trust was his priority, Matthew Autterson also focused on philanthropy. In 1993 he became a member and the Finance Chairperson of YPO also known as Young Presidents Organization for Denver. This volunteer organization is top area executives engaging in helping members and their communities through their knowledge, skills and influence across the globe. He was a volunteer for this program for 16 years with a focus on helping promote stronger education.
In 1998, Mr. Autterson expanded his philanthropic imprint by helping the Denver Zoo and the Denver Zoological Board and Foundation as Vice President of Finance. He continued his work with their animal welfare and zoological outreach for 10 years.
Today, Mr. Autterson is the President and Chief Executive Officer for Denver’s CNS Bioscience, Inc. The company CNS Bioscience is a clinical-stage drug development company. The company’s primary drug development focus is on alleviating neuropathic pain. Go Here for related Information.
In his spare time, Matthew is presently a volunteer member of the Board of Directors of Falci Adaptive Biosystems also known as FAB. The premier philanthropic goal of this nonprofit organization is helping people with neuromotor disabilities. Their focus is helping to increase their ability to interact and control their personal environments and thereby improve their lives. The foundation works closely with top medical centers who have a focus of specializing in neuromotor disabilities. He has been a volunteer with the organization since 2013.